Press 02/11/2014

Press Release

For immediate release

Contact person:

Oliver Liu
Company name: Radiant Genomics, Inc.
Telephone: 415-572-3901
Fax: 413-638-8166

Professor Jay Keasling joins Scientific Advisory Board of Radiant Genomics, Inc.


Emeryville, CA, February 1, 2014 – Radiant Genomics, Inc. is proud to announce that Dr. Jay Keasling, Professor of Chemical Engineering and Bioengineering at the University of California, Berkeley, Associate Laboratory Director for Biosciences at the Lawrence Berkeley National Laboratory (LBNL), the Founding Head of the Synthetic Biology Department in the Physical Biosciences Division at LBNL and CEO of the Joint BioEnergy Institute, has joined the Scientific Advisory Board of Radiant Genomics, Inc. Dr. Keasling is consided one of the foremost authorities in the fields of synthetic biology and metabolic engineering.


“It is a great honor to have Dr. Jay Keasling on our Scientific Advisory Board. He brings enormous expertise in synthetic biology, metabolic engineering, and industrial processes to our Board, as well as a passion for creating technologies that can impact how the world works ,” says Dr. Jeffrey Kim, CSO of Radiant Genomics. “We look forward to his input and advice as we build the next-generation in natural product discovery platforms.”


In 2009, Dr. Keasling was award the first annual Biotech Humanitarian Award by BIO (Biotechnology Industry Organization). In 2004, the Bill and Melinda Gates Foundation awarded a $42.5 million grant to develop and distribute a low-cost malaria treatment based on Dr. Keasling’s research. In 2006, Discover magazine awarded its first ever Scientist of the Year Award to Dr. Keasling.


About the Company

Radiant Genomics, Inc. was founded in 2012 with the goal of integrating a range of novel technologies including large-scale sequencing, synthetic biology, bioinformatics, cloud computing, metabolic engineering, and high-throughput analytical chemistry to develop a robust industrial platform for natural product discovery, diversification, and production. Radiant Genomics utilizes this platform to develop products in numerous market categories including pharmaceuticals, agriculture, specialty chemicals, and nutraceuticals.